These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3485440)

  • 21. Effect of hydrocortisone on human natural killer activity and its modulation by beta interferon.
    Fuggetta MP; Graziani G; Aquino A; D'Atri S; Bonmassar E
    Int J Immunopharmacol; 1988; 10(6):687-94. PubMed ID: 3198305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of effect of LTB4 on human natural killer cell activity and T lymphocyte transformation.
    Hall TJ; Brostoff J
    Immunol Lett; 1985; 9(5):255-8. PubMed ID: 2987110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corticosteroids in human lymphocyte-mediated cytotoxic reactions: effects on the kinetics of sensitization and on the cytolytic capacity of effector lymphocytes in vitro.
    Balow JE; Hunninghake GW; Fauci AS
    Transplantation; 1977 Apr; 23(4):322-8. PubMed ID: 141115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro natural killer and killer cell functions in uremia.
    Langhoff E; Ladefoged J
    Int Arch Allergy Appl Immunol; 1985; 78(2):218-20. PubMed ID: 3876291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral tibial marrow ablation in rats induces a rapid hypercalcemia arising from extratibial bone resorption inhibitable by methylprednisolone or deflazacort.
    Magnuson SK; Booth R; Porter S; Gorski JP
    J Bone Miner Res; 1997 Feb; 12(2):200-9. PubMed ID: 9041051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deficient natural killer function in patients receiving immunosuppressive drugs: analysis at the cellular level.
    Dupont E; Vandercruys M; Wybran J
    Cell Immunol; 1984 Oct; 88(1):85-95. PubMed ID: 6236888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of the anti-inflammatory steroid deflazacort to glucocorticoid receptors in brain and peripheral tissues. In vivo and in vitro studies.
    Coirini H; Flores D; Vega MC; Gonzalez Deniselle MC; De Nicola AF
    J Steroid Biochem Mol Biol; 1994 May; 49(1):43-9. PubMed ID: 8003438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells.
    Humphrey EL; Williams JH; Davie MW; Marshall MJ
    Bone; 2006 May; 38(5):652-61. PubMed ID: 16298558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of the glucocorticoids prednisolone, deflazacort and beclomethasone-dipropionate on the RM 3/1 macrophage in human peripheral blood.
    Zwadlo-Klarwasser G; Schmutzler W
    Skin Pharmacol Appl Skin Physiol; 1998; 11(4-5):227-31. PubMed ID: 9885406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in bone mass during low dose corticosteroid treatment in patients with polymyalgia rheumatica: a double blind, prospective comparison between prednisolone and deflazacort.
    Krogsgaard MR; Thamsborg G; Lund B
    Ann Rheum Dis; 1996 Feb; 55(2):143-6. PubMed ID: 8712867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation. Marked difference between prednisolone and methylprednisolone.
    Hirano T; Oka K; Takeuchi H; Sakurai E; Matsuno N; Tamaki T; Kozaki M
    Transplantation; 1994 May; 57(9):1341-8. PubMed ID: 8184473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoregulation of human natural killer cells (NK) by corticosteroids: inhibitory effect of culture supernatants.
    Nair MP; Schwartz SA
    J Allergy Clin Immunol; 1988 Dec; 82(6):1089-97. PubMed ID: 3204252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deflazacort: a glucocorticoid with few metabolic adverse effects but important immunosuppressive activity.
    Gonzalez-Perez O; Luquin S; Garcia-Estrada J; Ramos-Remus C
    Adv Ther; 2007; 24(5):1052-60. PubMed ID: 18029332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute effects of deflazacort and its metabolite 21-desacetyl-deflazacort on allergic reactions.
    Omote M; Sakai K; Mizusawa H
    Arzneimittelforschung; 1994 Feb; 44(2):149-53. PubMed ID: 7511903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes.
    Nair MP; Schwartz SA
    J Immunol; 1984 Jun; 132(6):2876-82. PubMed ID: 6202765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of human natural killer cell activity by platelet-derived growth factor. II. Membrane binding studies, effects of recombinant IFN-alpha and IL-2, and lack of effect on T cell and antibody-dependent cellular cytotoxicity.
    Gersuk GM; Chang WC; Pattengale PK
    J Immunol; 1988 Dec; 141(11):4031-8. PubMed ID: 2846698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Steroids on Natural Killer Cells Against Cytotoxicity and Hepatitis C Virus Replication.
    Ohira M; Nishida S; Tryphonopoulos P; Ruiz P; Ohdan H; Tzakis AG
    Transplant Proc; 2017 Jun; 49(5):1160-1164. PubMed ID: 28583548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents.
    Shin BH; Ge S; Mirocha J; Karasyov A; Vo A; Jordan SC; Toyoda M
    Transplantation; 2014 Feb; 97(3):294-300. PubMed ID: 24342979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bone loss during low dose glucocorticoid treatment in patients with polymyalgia rheumatica. A double-blind, prospective comparison between prednisolone and deflazacort].
    Krogsgaard MR; Thamsborg G; Lund B
    Ugeskr Laeger; 1997 Jul; 159(30):4641-4. PubMed ID: 9245040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assay.
    Martin-Kleiner I; Gabrilovac J
    Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):37-57. PubMed ID: 8683038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.